• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evaluation of Pharmacokinetics and Metabolism of Phosphorothioate Antisense Oligonucleotide G3139 in Rat by Capillary Electrophoresis with Laser-Induced Fluorescence.

作者信息

Ban Eunmi, Kwon Haejin, Song Eun Joo

机构信息

College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.

出版信息

Nucleic Acid Ther. 2021 Aug;31(4):316-320. doi: 10.1089/nat.2020.0922. Epub 2021 Mar 30.

DOI:10.1089/nat.2020.0922
PMID:33784473
Abstract

A sensitive and specific capillary electrophoresis with laser-induced fluorescence (CE-LIF) and a simple extraction process was developed to simultaneously detect G3139 and its metabolites as a model of antisense oligonucleotides (ASOs). This method has shown excellent linearity within the tested concentration range for G3139 and its metabolites, with a detection limit of 3.0 pM and a recovery of >84.2%. Based on our developed plasma extraction method, we have evaluated the pharmacokinetics and metabolites from rat plasma after intravenous administration of G3139 at 0.76 mg/kg. The results showed that G3139 and its metabolites were successfully simultaneously detected and analyzed through a single run using CE-LIF with baseline separation until the 30-h test sampling time point. The half-life of G3139 and its metabolites was observed at 31 and 68 h, respectively. This study may provide an effective analytical method for the pharmacokinetic and metabolite evaluation required to develop ASOs to treat a variety of diseases.

摘要

相似文献

1
Evaluation of Pharmacokinetics and Metabolism of Phosphorothioate Antisense Oligonucleotide G3139 in Rat by Capillary Electrophoresis with Laser-Induced Fluorescence.
Nucleic Acid Ther. 2021 Aug;31(4):316-320. doi: 10.1089/nat.2020.0922. Epub 2021 Mar 30.
2
Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.G3139(一种针对bcl-2的硫代磷酸酯寡脱氧核苷酸反义药物)在对小鼠静脉注射或持续皮下输注后的药代动力学。
J Pharmacol Exp Ther. 1997 Apr;281(1):420-7.
3
Pharmacokinetics of Bcl-2 antisense oligonucleotide (G3139) combined with doxorubicin in SCID mice bearing human breast cancer solid tumor xenografts.Bcl-2反义寡核苷酸(G3139)联合阿霉素在携带人乳腺癌实体瘤异种移植瘤的SCID小鼠体内的药代动力学
Cancer Chemother Pharmacol. 2002 Jan;49(1):57-68. doi: 10.1007/s00280-001-0385-3.
4
Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry.采用离子对反相高效液相色谱-电喷雾离子阱质谱联用技术对血浆和尿液中的Bcl-2反义核酸G3139及其代谢产物进行表征和定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Oct 25;825(2):201-13. doi: 10.1016/j.jchromb.2005.05.049. Epub 2005 Aug 18.
5
Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo.体外和体内研究中性胞苷脂质结合阳离子脂质包封的反义寡核苷酸 G3139 的结构优化和额外靶标鉴定。
Biomaterials. 2019 Mar;197:182-193. doi: 10.1016/j.biomaterials.2018.12.033. Epub 2019 Jan 3.
6
Preconcentration and separation of antisense oligonucleotides by on-column isotachophoresis and capillary electrophoresis in polymer-filled capillaries.在填充聚合物的毛细管中通过柱上等速电泳和毛细管电泳对反义寡核苷酸进行预浓缩和分离。
Electrophoresis. 1998 Jun;19(8-9):1445-51. doi: 10.1002/elps.1150190839.
7
Quantitative nuclear and cytoplasmic localization of antisense oligonucleotides by capillary electrophoresis with laser-induced fluorescence detection.
Electrophoresis. 2001 Oct;22(17):3765-70. doi: 10.1002/1522-2683(200109)22:17<3765::AID-ELPS3765>3.0.CO;2-Y.
8
Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer.BCL-2反义寡核苷酸(G3139)通过持续静脉输注给药用于晚期癌症患者的I期试验。
Clin Cancer Res. 2002 Mar;8(3):679-83.
9
Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.Bcl-2反义核酸(G3139,Genasense)增强了爱泼斯坦-巴尔病毒相关淋巴增殖性疾病对利妥昔单抗的体外和体内反应。
Clin Cancer Res. 2003 May;9(5):1931-9.
10
Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.与bcl-2反义寡核苷酸G3139联合游离及脂质体阿霉素治疗相关的分子和药代动力学特性。
Clin Cancer Res. 2000 Jul;6(7):2891-902.